FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897079850> ?p ?o ?g. }

• W2897079850 endingPage "264" @default.
• W2897079850 startingPage "255" @default.
• W2897079850 abstract "Natural Killer cells (NK) are innate effector cells with a critical role in immunosurveillance against different kinds of cancer cells, including Multiple Myeloma (MM). However, the number and/or function of these lymphocytes are strongly reduced during MM progression and in advanced clinical stages. A better understanding of the mechanisms controlling both MM and NK cell biology have greatly contributed to develop novel and combined therapeutic strategies in the treatment of this incurable hematologic malignancy. These include approaches to reverse the immunosuppressive MM microenvironment or potentiate the natural or antibody-dependent cellular cytotoxicity (ADCC) of NK cells. Moreover, chemotherapeutic drugs or specific monoclonal antibodies (mAbs) can render cancer cells more susceptible to NK cell-mediated recognition and lysis; direct enhancement of NK cell function can be obtained by means of immunomodulatory drugs, cytokines and blocking mAbs targeting NK cell inhibitory receptors. Finally, adoptive transfer of ex-vivo expanded and genetically manipulated NK cells is also a promising therapeutic tool for MM. Here, we review current knowledge on complex mechanisms affecting NK cell activity during MM progression. We also discuss recent advances on innovative approaches aimed at boosting the functions of these cytotoxic innate lymphocytes. In particular, we focus our attention on recent preclinical and clinical studies addressing the therapeutic potential of different NK cell-based strategies for the management of MM." @default.
• W2897079850 created "2018-10-26" @default.
• W2897079850 creator A5011046435 @default.
• W2897079850 creator A5013314995 @default.
• W2897079850 creator A5017694699 @default.
• W2897079850 creator A5024871281 @default.
• W2897079850 creator A5040070739 @default.
• W2897079850 creator A5054193089 @default.
• W2897079850 creator A5062614877 @default.
• W2897079850 creator A5063846820 @default.
• W2897079850 creator A5074159017 @default.
• W2897079850 creator A5081879325 @default.
• W2897079850 date "2018-11-01" @default.
• W2897079850 modified "2023-10-12" @default.
• W2897079850 title "Translating the anti-myeloma activity of Natural Killer cells into clinical application" @default.
• W2897079850 cites W13743986 @default.
• W2897079850 cites W1481809543 @default.
• W2897079850 cites W1487745522 @default.
• W2897079850 cites W1497582288 @default.
• W2897079850 cites W1555729280 @default.
• W2897079850 cites W1591236327 @default.
• W2897079850 cites W1820495241 @default.
• W2897079850 cites W1891577135 @default.
• W2897079850 cites W1902692042 @default.
• W2897079850 cites W1955732360 @default.
• W2897079850 cites W1963940744 @default.
• W2897079850 cites W1969464492 @default.
• W2897079850 cites W1969814796 @default.
• W2897079850 cites W1970074537 @default.
• W2897079850 cites W1971712854 @default.
• W2897079850 cites W1975506876 @default.
• W2897079850 cites W1988998251 @default.
• W2897079850 cites W1994013901 @default.
• W2897079850 cites W1997617188 @default.
• W2897079850 cites W1997952190 @default.
• W2897079850 cites W1998007325 @default.
• W2897079850 cites W2000130439 @default.
• W2897079850 cites W2005578318 @default.
• W2897079850 cites W2009549519 @default.
• W2897079850 cites W2010181990 @default.
• W2897079850 cites W2010232494 @default.
• W2897079850 cites W2012633939 @default.
• W2897079850 cites W2012959199 @default.
• W2897079850 cites W2014018534 @default.
• W2897079850 cites W2015345028 @default.
• W2897079850 cites W2018580749 @default.
• W2897079850 cites W2021924499 @default.
• W2897079850 cites W2022580424 @default.
• W2897079850 cites W2023283620 @default.
• W2897079850 cites W2023319194 @default.
• W2897079850 cites W2025755104 @default.
• W2897079850 cites W2029458815 @default.
• W2897079850 cites W2030629522 @default.
• W2897079850 cites W2046651418 @default.
• W2897079850 cites W2053841483 @default.
• W2897079850 cites W2056315817 @default.
• W2897079850 cites W2058817587 @default.
• W2897079850 cites W2060439989 @default.
• W2897079850 cites W2060520161 @default.
• W2897079850 cites W2066448438 @default.
• W2897079850 cites W2067155443 @default.
• W2897079850 cites W2068412287 @default.
• W2897079850 cites W2076248543 @default.
• W2897079850 cites W2076345036 @default.
• W2897079850 cites W2076352025 @default.
• W2897079850 cites W2079076243 @default.
• W2897079850 cites W2086278185 @default.
• W2897079850 cites W2087025602 @default.
• W2897079850 cites W2089107230 @default.
• W2897079850 cites W2090083883 @default.
• W2897079850 cites W2099126386 @default.
• W2897079850 cites W2099308699 @default.
• W2897079850 cites W2109176206 @default.
• W2897079850 cites W2110544227 @default.
• W2897079850 cites W2112171779 @default.
• W2897079850 cites W2115953354 @default.
• W2897079850 cites W2117887415 @default.
• W2897079850 cites W2128644254 @default.
• W2897079850 cites W2131152519 @default.
• W2897079850 cites W2132557616 @default.
• W2897079850 cites W2132835748 @default.
• W2897079850 cites W2135404380 @default.
• W2897079850 cites W2135688355 @default.
• W2897079850 cites W2141502099 @default.
• W2897079850 cites W2146313292 @default.
• W2897079850 cites W2147423551 @default.
• W2897079850 cites W2152105313 @default.
• W2897079850 cites W2155339987 @default.
• W2897079850 cites W2170918668 @default.
• W2897079850 cites W2199893196 @default.
• W2897079850 cites W2267145540 @default.
• W2897079850 cites W2324439784 @default.
• W2897079850 cites W2339180622 @default.
• W2897079850 cites W2410581153 @default.
• W2897079850 cites W2412725897 @default.
• W2897079850 cites W2434567203 @default.
• W2897079850 cites W2443548094 @default.
• W2897079850 cites W2486455593 @default.

• next